12 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment algorithms ... Chronic Obstructive Lung ... LAMA: long-acting ... muscarinic antagonist; LABA ... #Management #Pulmonary
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Medical Treatment Algorithm ... Chronic Obstructive Pulmonary ... corticosteroid; LABA ... COPD #Treatment #Algorithm ... #Management #Pulmonary
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
receptor antagonists; LABA ... : long-acting β2 ... #GINA #Asthma #Management ... #Stepwise #Pulmonary ... StepUp #Treatment #Algorithm
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... affecting the lungs ... • Lymphoma • Lung ... • Progressive lung ... #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... affecting the lungs ... • Lymphoma • Lung ... • Progressive lung ... #Diagnosis #Management
Noncardiogenic Pulmonary Edema - Differential Diagnosis Framework

NCPE Pathophysiology:
Noncardiogenic pulmonary edema occurs because of excessive pulmonary capillary
Framework NCPE Pathophysiology ... History/Physical/Labs ... • Heart size: Normal ... ECHO: • Normal ... Transfusion-related acute lung
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... Abscess Pathophysiology ... Abscess Management ... westermani • Other: TB ... #Abscess #pulmonary
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
ATRA treatment Pathophysiology ... Diagnosis: • Labs ... Imaging: CXR- pulmonary ... 500 mg QD until normal ... APML #diagnosis #management
Sarcoidosis - Diagnosis and Management Summary
Epidemiology
1) High incidence in Scandinavian countries (11-24 cases per 100,000 individuals
Diagnosis and Management ... survival is 93-95% Pathophysiology ... granulomas within the lungs ... Pulmonary: dyspnea ... ), liver (pain/abnormal
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
Amiodarone Induced Lung ... Direct cytotoxic lung ... Labs: • Nonspecific ... Eosinophilia • Normal ... #diagnosis #management